On September 25, 2024, Glass Technology Services is set to host the much-anticipated “Future of Pharma Glass Packaging Forum.”
This conference promises to be an enlightening experience, delving deep into the latest technological advancements, regulatory updates, and innovative solutions that are reshaping the pharmaceutical glass packaging industry.
The forum will showcase a lineup of expert speakers from Glass Technology Services, each bringing a wealth of knowledge and experience in mechanical testing methods, chemical durability assessments, and advanced glass analysis techniques. Attendees can look forward to engaging discussions focused on critical topics such as failure analysis, quality assurance, glass properties, and environmental considerations—all essential for navigating today’s complex packaging landscape.
As the pharmaceutical industry evolves, so too do the regulatory frameworks that govern it. Notably, the U.S. Pharmacopeia (USP) has recently revised its definition of Type 1 glass, while the Parenteral Drug Association (PDA) has updated its classifications concerning defects in empty glass containers. These significant changes present crucial implications for how pharmaceutical companies approach product packaging. The “Future of Pharma Glass Packaging Forum” will provide participants with a comprehensive understanding of these shifts, equipping them with the knowledge they need to make informed packaging choices.
Discussion topics will include strategies for minimizing glass waste, early identification of delamination, and optimizing packaging processes. These insights are essential for professionals striving to stay ahead in an ever-evolving industry.
Event Agenda Highlights:
– Introduction to Glass Technology Services: Understand the mission and innovations driving the company’s commitment to excellence in glass packaging.
– Overview of Regulatory Updates: With a focus on USP <660> PF issue 49(4) effective January 1, 2024, explore how these updates grant increased flexibility and altered inspection criteria, as well as strategies for addressing non-conformances.
– Novel Type 1 Vials: Examine the benefits of utilizing new, non-borosilicate “Type 1” vials in your pharmaceutical packaging strategy.
– Understanding Delamination: Gain insights into what delamination is, its early signs, and the best packaging choices to mitigate risks.
– Fracture Analysis: Discover effective methods for addressing breakages on the production line, utilizing fracture analysis to identify key process stages for improvement.
– The Future of Pharma Glass Packaging: Collaboratively explore innovative pathways to reduce waste, enhance recycling efforts, and leverage advancements in borosilicate glass technology.
The “Future of Pharma Glass Packaging Forum” is poised to be an invaluable event for all professionals within the pharmaceutical packaging sector. Join us for a day dedicated to learning, collaboration, and innovation, as we collectively shape the future of pharma glass packaging. Mark your calendars for September 25, 2024, and prepare to engage with industry leaders and peers working toward a sustainable and efficient packaging future. Don’t miss this opportunity to be part of an essential conversation for the advancement of our industry.
Source:Glass Technology Services with additional information added by GlassBalkan
